Evidence map›Paper›PMID 26712606›Full record

ArticleExperimental eye research2016

Characterization of Inhibitor of differentiation (Id) proteins in human cornea.

Rajiv R Mohan, Brandie R Morgan, Govindaraj Anumanthan, Ajay Sharma, Shyam S Chaurasia, Frank G Rieger

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Long-Term Tolerability and Safety of AAV5-Id3 Gene Therapy to Eyes.Translational vision science & technology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Role ofMolecular vision · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Rajiv R MohanHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA; Department of Ophthalmology, College of Veterinary Medicine, Columbia, MO, USA; Department of Biomedical Sciences, College of Veterinary Medicine, Columbia, MO, USA; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, USA. Electronic address: MohanR@health.missouri.edu.
Brandie R MorganHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA; Department of Ophthalmology, College of Veterinary Medicine, Columbia, MO, USA.
Govindaraj AnumanthanHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA; Department of Ophthalmology, College of Veterinary Medicine, Columbia, MO, USA.
Ajay SharmaHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA; Department of Ophthalmology, College of Veterinary Medicine, Columbia, MO, USA.
Shyam S ChaurasiaDepartment of Ophthalmology, College of Veterinary Medicine, Columbia, MO, USA; Department of Biomedical Sciences, College of Veterinary Medicine, Columbia, MO, USA.
Frank G RiegerHarry S. Truman Memorial Veterans' Hospital, Columbia, MO, USA; Mason Eye Institute, School of Medicine, University of Missouri, Columbia, MO, USA.
Missouri College · USHarry S. Truman Memorial Veterans' Hospital · USUniversity of Missouri · US

Funding

Gene Therapy in the CorneaR01EY017294 · NEI · UNIVERSITY OF MISSOURI-COLUMBIA · PI MOHAN, RAJIV RAVINDRA · 2007 to 2018
$4.3M
Targeted Gene Therapy and Nanomedicine Approaches to Treat Corneal DiseasesI01BX000357 · VA · HARRY S. TRUMAN MEMORIAL VA HOSPITAL · PI Rajiv Ravindra Mohan · 2009 to 2026
–
BLRD VA I01 BX000357NEI NIH HHS R01 EY017294
6 · The paper itself

Abstract

Inhibitor of differentiation (Id) proteins are DNA-binding transcription factors involved in cellular proliferation, migration, inflammation, angiogenesis and fibrosis. However, their expression and role in the cornea is unknown. The present study was undertaken to characterize the expression of Id proteins and their interactions with the pro-fibrotic cytokine Transforming Growth Factor β1 (TGFβ1) and anti-fibrotic cytokine, bone morphogenic protein 7 (BMP7) in human cornea. Human donor corneas procured from Eye Bank were used. Id proteins were localized in human corneal sections using immunofluorescence. Primary cultures of human corneal fibroblasts (HCF) were established and treated with either TGFβ1 (5 ng/ml) or BMP7 (10 ng/ml) for 24 h in serum free medium. Expression of Id's in response to TGFβ1, BMP7 and TGFβ1 + BMP7 was analyzed by quantitative real time PCR (qRT-PCR) and western blot analysis. Id1 and Id2 proteins were ubiquitously expressed in the epithelial cells and stromal keratocytes in human cornea. The Id1 was localized to the basal epithelial cells as seen by immunohistochemistry. HCF expressed all known mammalian Id genes (Id1-Id4). In addition, Id1 and Id2 are selectively expressed in HCF. Treatment of human recombinant TGFβ1 (5 ng/ml) to serum-starved HCF showed a significant increase in Id genes (Id1, Id2 and Id4) at 2 h time point compared to BMP7 treatment, which showed time dependent increase in the expression of Id1-Id3 at 24-48 h. Combined treatment with TGFβ1 + BMP7 to HCF showed a significant increase in Id1 transcript and an increasing trend in Id3 and Id4 expression. The results of this study suggest that Id family of genes (Id1-Id4) are localized in the human cornea and expressed in the corneal fibroblasts. Also, Id's were differentially regulated with TGFβ1 and/or BMP7 in a time dependent manner and might serve as a therapeutic target in corneal fibrosis.

Indexed as

Gene Expression RegulationBlotting, WesternCell DifferentiationCells, CulturedCorneaCorneal DiseasesFibroblastsHumansImmunohistochemistryInhibitor of Differentiation ProteinsReal-Time Polymerase Chain ReactionRNAInhibitor of Differentiation ProteinsRNABone morphogenic protein 7CorneaCorneal fibrosisDifferentiationId proteinsProliferationTransforming growth factor β1

Identifiers

PMID26712606
PMCPMC4893967
OpenAlexW2208572247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.